Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Sidney Kimmel Comprehensive Cancer Center

ClinicalTrials.gov Identifier:

NCT00847171

First received: February 18, 2009

Last updated: November 15, 2012

Last verified: November 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2012 (Final data collection date for primary outcome measure)